Progenitor is focused helping Pharmaceutical companies work successfully in the Emerging Markets while having global accountability in Europe. Progenitor International Research is a niche provider of emerging market solutions composed of professionals in Asia, India, Latin America (Argentina, Chile, Panama, Colombia, Venezuela, and Brazil) and South Africa. We offer a turn-key solution to emerging market needs in terms of the scope of services that are provided: Phase I through IV clinical research services, Quality Assurance services, Regulatory and Medical Affairs and Pharmacovigilance. The key points that differentiate Progenitor International Research from other global CROs offering emerging market solutions are: o Commitment to emerging market solutions. Focused expertise in these regions allows for committed approach to success in these regions. o Focus on experienced staff. o In-depth Phase I-IV emerging market experience working with top pharmaceutical companies with numerous successful sponsor audits o Better value in terms of pricing (our pricing can be 30-40% less than the price of our competitors) due to the low overhead structure of our company. Our goal is to pass the value of the labor market onto our customers. o Quality assurance teams located in the emerging markets o Therapeutic specialists in each region who have expert knowledge and relationships with key physicians in their local markets. o Scientific, medical and regulatory consultation based upon global drug development expertise.